Académique Documents
Professionnel Documents
Culture Documents
Wang Guoqing
Department of Physiology, Medical School, Soochow University, Suzhou 215123, China
I. II. Physical and chemical characteristics of blood III. Blood Cells 1. Hemopoietic process and hemopoietic stem cells 2. Hemopoietic microenvironment 3. Erythrocyte Physiology 4. Leukocyte Physiology 5. Platelet or Thrombocyte Physiology IV. Physiological Hemostasis 1. Endocrine functions of vessel endothelial cells 2. Physiological Characteristics of Platelet 3. Blood Coagulation 4. Fibrinolysis V. Blood Group 1. RBC Agglutination 2. ABO blood group system 3. Rh blood group system 4. Relation between blood volume and clinic 5. Principle of Transfusion and Cross-match test
Outline
Blood is that part of extracellular fluid within the cardiovascular system Blood forming During animals evolution, extracellular fluid was gradually shaped from the age-old time with ocean which was mainly salty solution. At last, extracellular fluid was differentiated into plasma and interstitial fluid and blood came from plasma and cells. The role of blood in internal environmental homeostasis Blood, the most active component in extracellular fluid, display functions as follows:
I. Blood composing
Blood composing: plasma + blood cells Hematocrit: blood cells occupies the percentage of total blood volume. normal value male: 40-50% female: 37-48% newborn: 55%
Water: > 90% Small molecule: 2%, it is electrolytes, nutriment, metabolic products, hormone, enzyme,etc. Protein: 60-80 g/L, plasma protein include albumin (40-50 g/L), globulin (20-30 g/L,1-, 2, -, - ) and fibrinogen. Most of albumin and globulin made from liver. A/G and clinic. Function of plasma protein: (1) transportation, (2) nutrition, (3) forming colloid osmotic pressure, (4) coagulation and anticoagulation, (5) pH value buffer, (6) immunity (globulin)
12 4 <0.001 139 29 54
(Unitmmol/L)
Specific gravity: total blood (1.050-1.060) more influenced by red blood cells; plasma (1.025-1.030) more influenced by plasma protein; RBC (1.090-1.092) more influenced by Hb. Viscosity: Blood relative viscosity (4~5) mainly depends on the numbers of red blood cells. Plasma relative viscosity (1.6~2.4) is mainly involved in plasma protein Plasma osmotic pressure is 300 mmol/L or 770kPa (1) Crystal osmotic pressure results from NaCl and modulates water distribution between inside and outside of cells. (2) Colloid osmotic pressure results from albumin and regulates water distribution between inside and outside of capillary. Plasma pH value is about 7.35~7.45, and usually buffer systems are NaHCO3/H2CO3 (20:1), protein salt/protein, Na2HPO4/ NaH2PO4, Hb salt/Hb, HbO salt/ HbO2, K2HPO4/ KH2PO4, KHCO3/H2CO3, etc [lungs and kidney mainly regulate Plasma pH value ].
Water
[Water] > [Water] [Salt] < [Salt] Osmotic Pressure < Osmotic Pressure Osmosis is the movement of water from a high concentration to a low concentration. In this illustration, two compartments (A and B) are separated by a semipermeable membrane (broken vertical line). The water concentration in compartment A is greater than the concentration in compartment B because of the presence of salt (X) in B. Therefore, water will move down its concentration gradient from A to B. The force needed to prevent this water movement is called osmotic pressure.
Tonicity
The tonicity of a solution refers to the effect of the solution on cell volume. A hypertonic extracellular solution is one in which the water concentration is less outside the cell than inside; water leaves the cell; cell volume decreases. An isotonic extracellular solution is one in which the water concentration is the same inside and outside the cell; no water movement; cell volume does not change. A hypotonic solution is one in which the water concentration is greater outside than inside the cell; water enters the cell; cell volume increases. An isosmotic solution may not be an isotonic solution if the particles are permeable to the cell membrane.
III.Blood Cells
Blood cells are erythrocyte (red blood cell, RBC), leukocyte (white blood cell, WBC) and thrombocyte (platelet, P).
Blood Cells
The forming processes of erythrocyte (red blood cell, RBC), leukocyte (white blood cell, WBC) and thrombocyte (platelet, P) originating from hematopoietic stem cells are hemopoiesis. Transfer of blood cells forming place: yolk sac hemopoiesis (early embryo period) liver and spleen (second embryo month) marrowand liver, spleen (after fourth embryo month) marrow (fetus birth time) and liver, spleen as complementary role. During adulthood (after 18), red marrow (flat bones, e.g. vertebra,ilium, sternum, rib, skull and long bone ending) rather than yellow marrow has hematopoietic functions.
Basic characteristics Self renewal in high degree, constant from young to old age. Multi- directional differentiation Large potential proliferation, Hemopoietic stem cells produce about 11011 blood cells releasing to blood for use. Surface sign According to CFU (colony forming unit), using fluorescence-activated cell sorting (FACS), its main surface sign is CD34+CD38-Lin-and CD34-CD38-Lin-. Note CD: cluster of differentiation of antigen on the white blood cells; Lin: systemic specific antigen on the hemopoietic cells.
2.Hemopoietic microenvironment
Hemopoietic microenvironment: It includes stromal cell secreting extracellular matrix (ECM), multihemopoietic regulating factor, hemopoietic nerves and blood vessels. Stromal cells in the marrow come from fibrocyte, reticulocyte, endothelial cell, ectoblast cell, monocyte, engulfing cell, osteoblast and osteoclast. Stromal cells supply two material: one is soluble hemopoietic growth factor, another is membrane-combined adhesive molecule. Extracellular stroma synthesized and secreted by marrow stromal cell filling cellular interstice contains big molecules, such as collagen (typeI, II, III, IV), glycoprotein (fibronectin, laminin, hemopoieticnectin ) and protein amylose (sulfate cartilagetin, sulfate heparin, hyaluronic acid and sulfate dermatin, etc). Hemopoietic cells must adhere to stromal cell and is in the hemopoietic microenvironment for survival.
Hemopoietic process
Hemopoietic process
Hemopoietic process
3.Erythrocyte Physiology
Shape and number of red blood cells (RBC) Shape of RBC: like biconcave disc
Its diameter is about 7~8 m, peripheral thickness about 2.5 m, central thickness about 1 m and cubage about 90 m3.
Erythrocyte Physiology
Number of RBC: It is most numbers in the blood. Normal value about RBC Male adult, 4.5~5.51012/L; average, 5.01012/L Female adult, 3.8~4.6 1012/L; average, 4.21012/L Newborn, 6.01012/L Protein within RBC is hemoglobin (Hb). Hb in male adult, 120~160 g/L; Hb in female adult, 110~150 g/L; Hb in newborn (within 5 days), 200 g/L Pregnant female, numbers of RBC and Hb are relatively less (because of more plasma). Dweller lived in plateau, numbers of RBC and Hb are relatively more (because of compensation for anoxia).
Plasticity and metamorphose depend on: 1) surface area-cubage ratio, 2) viscosity of Hb, 3) membrane elasticity and viscosity.
RBC can be used for transportation of O2 and CO2 in the blood. RBC can be served as pH buffer.
Erythropoiesis
Hemopoietic material for erythropoiesis: iron (Fe++) and protein, [reason for anemia] Influencing factors of RBC maturity: Vitamin B12 and folic acid (DNA metabolism), [clinic relation] Process of erythropoiesis:
Hemopoietic stem cellsmulti systemic hemopoietic progenitor cellsRBC-committed progenitor cells (BFU-ECFUE)original RBC earlier infantile RBCmedium-term infantile RBCterminal infantile RBCreticular RBCmature RBCblood for circulation.
Regulation of Erythropoiesis
0.8% of total RBCs has self renewal, that is to say, 160106 RBC production every minute. Burst forming unit-erythroid, BUF-E, important to earlier erythropoiesis, depends on stimulation of burst promoting activity, BPA outside body. BPA made by leucocyte is a glycoprotein whose molecular weight is about 25000~40000 Colony forming unit-erythroid, CFU-E, important to terminal erythropoiesis, depends on erythropoietin, EPO which is also a glycoprotein, molecular weight, 34000, plasma concentration 10 pmol/L, half life 5 hours, increasing release when anoxia.
Regulation of Erythropoiesis
Life-span: 120 days, about 4 months, each RBC circulates 27 km averagely in vessels, short life-span for aged RBC Breakage: places are liver, spleen and lymphatic node, and after breakage, Hb released from RBC immediately combine with plasma 2-globulin (Hb touched protein) which is taken in by liver for iron reuse.
Hb, very toxic if it get into blood, normally, it can be metabolized into bile pigment in liver.
Clinic relation.
Percentage (%)
Neutrophil (bacilliform nucleus) 0.04~0.5 Neutrophil (foliiform nucleus) Eosinophil Basophil Monocyte Lymphocyte 2.0~7.0 0.02~0.5 0.0~0.1 0.12~0.8 0.8~4.0
Newborn: Number is higher, 15109/L, after birth 3 or 4 days to 3 months, being about 10109/L, mainly, neutrophil, 70%; secondarily, lymphocyte. Circadian changes: Number of WBC is more in the afternoon than in the morning. Food taking, ache and mood excitation: Number of WBC is remarkably higher. Heavy exercise and laboring: Increasing numbers, about 35109/L, return to original level after action stop. Terminal pregnancy of female: Numbers changes in 12~17109/L, and during parturition, 34109/L, and after parturition 2~5 days, number return to original level.
Terminology Diapedisis: Metamorphosed WBCs pass through vessel wall getting into interstitial fluid. Chemotaxis: It is a process that WBCs shift to some chemical material (metabolic production, antigen-antibody complex, bacteria, toxin, etc). Phagocytosis: It is a process that WBCs enclose and engulf exotic or extraneous material, and use intracellular enzyme digesting them.
WBC Diapedisis
Blood Vessel
Metamorphose
Another name, polymorphonuclear, PMN, 6~8 h in the vessels, diapedisis, chemotaxis and phagocytosis (using its hydrolyzed enzyme) Function: It plays a very important role in nonspecific cellular immunity system which is against pathogenic microorganism, such as bacteria, virus, parasite, etc. Clinic relation: Number of neutrophil greatly increase occurring in acute inflammation and earlier time of chronic inflammation. number decrease of neutrophil will result in poor resistibility and easily suffering from infection.
opsonization.
Clinic relation: Its number increase when person suffers from parasite infection or allergic reaction.
Birth place: bone marrow, originating from hemopoietic stem cells, and leukopoiesis process is similar to RBC. Leukopoiesis, differentiation and growth are influenced by hemopoietic growth factor, HGF which are glycoprotein secreted by lymphocyte, monocytemacrophage, fibrous cell and endothelial cell. Colony stimulating factor, CSF, such as GM-CSF, G-CSF, M-CSF, Multi-CSF (IL-3) also influence Leukopoiesis. Life span: several hours to 3 or 4 days. Leukocyte breakage: site are liver, spleen and lymphatic node. Pus or purulence forming
Shape: Biconvex disk like, diameter about 2~4 m, average cubage 8 m3. Complicated structure: under the electronic microscope, there are -granule, dense body, lysin peroxide enzyme, opening tubular system, dense tubular system, canaliculus,etc. Dense body: It contains ADP, ATP, 5-HT, Ca2+, epinephrine,etc. Source: Platelet comes from megakaryocyte fractionlet release in the marrow.
Normal value: 100109 ~ 300109, range from 6%~10% Normal changes: more number in the afternoon than in the morning, more in winter than in spring, more in the venous blood than capillary, after sport, pregnacy. *Functions: 1. It maintains capillary endothelial cells smooth and integrated (repairing endothelium and providing nutrition). 2. It is involved in physiological hemostasis. Platelet and clinic relation: decrease of platelet, abnormal immune reaction, will results in hemorrhage or bleeding, purpuric symptom.
Platelet forming: Birth place is bone marrow, originating from hemopoietic stem cells, and differentiating into burst forming unitmegakaryocyte, BFU-MK, then continuously into CFU-MK, and into megakaryocyte, demarcation membrane system, DMS, into fractionlet release to the blood requiring 8~10 days. (one megakaryocyte can produce 200~7700 platelet). Regulation: Protein, Mpl, expressed by c-mpl (oncogene) exists in CD34+ located at hemopoietic stem cells/ committed progenitors, megakaryocyte and platelet, found by Methin in 1993, and its ligand named thrombopoietin, TPO was discovered in 1994 which promoted hemopoietic stem cells differentiating into megakaryocyte as hemopoietic stem cells positive regulating factor.
Physiological Hemostasis
Inactive Platelet
Under the electronic microscope
Thrombocyte adhesion: its membrane glycoprotein (GP, GPIb/IX and GPIIa/IIIb), collagen (underendothelial structure), vWF (plasma component), fibrinogen are involved in adhesion. Mechanism: Exposed collagen+vWF vWF changes platelet membrane glycoprotein+changed vWF Thrombocyte adhesion. Thrombocyte aggregation: induced by physiological factors such as ADP, thromboxane A2 (TXA2), epinephrine, 5-HT, histamine, collagen, thrombin, prostacyclin,etc and by pathological factors like bacteria, virus, immune complex, drugs, etc. The process can be separated into two phases: phase one is reversible aggregation and phase two irreversible aggregation. Two phases require Ca2+, fibrinogen and energy consumption. Mechanism : Various factors+corresponding receptors on the platelet changes in the second messenger within platelet cAMP, Ip3, Ca2+, cGMP platelet aggregation. Thrombocyte release: ADP, ATP, 5-HT, Ca2+ released from dense body, and -platelet globin, PF4, vWF, fibrinogen, PFV, PDGF, thrombin sensitive protein from -granule, and acid protein hydrolyzed enzyme, tissue hydrolyzed enzyme from lysosome. Thrombocyte contraction: Loose platelet thrombus could turn into compact platelet thrombus by Ca2+ release and cytoskeleton movement (filament/canaliculus) within platelet.
Activation of platelet: Stimulus brings about thrombocyte adhesion, aggregation, release and contraction. Loose platelet thrombus forming: First phase of hemostasis. Blood coagulation activation by platelet: Fibrin net forming, second phase of hemostasis. *Roles of platelet in hemostasis: 1. Activated platelets supply lecithoid (phospholipid) surface for blood clotting factor and involve in activating factor X and prothrombin. 2. Surface of platelet membrane combine with many blood clotting factor, such as fibrinogen, FV, FXI, FXIII to speed up coagulation. 3. Activated platelets release -granule which contains fibrinogen to intensify fibrin forming and blood coagulation. 4. Activated platelets contract clot with its contractive protein to solidify blood coagulation.
Second Phase
Definition: The process of blood flow from flowing liquid to gel or gelatin. Serum: Light yellow fluid after blood coagulation. Difference between serum and plasma mainly consists in no fibrinogen in serum. Blood coagulation is a series of complicated biochemical reactions with various enzymes. Blood clotting factor: Material which are directly involved in blood coagulation. There are 12 factors named Roman numerals, except Ca2+, phospholipidother factors being protein, and except FIII (TF), others are in fresh plasma synthesized by liver with VitK . Blood clotting enzymes have two type: inactive and activated type [FII, FVII, FIX, Fx, FXI, FXII, FXIII].
2d 2~3 d
24 h 8d -
13 4
5 6,1 3 4
Blood Coagulation
Intrinsic pathway of blood coagulation: All blood clotting factors involved in blood coagulation come from blood. Eyewinker surface with negative charges (collagenin) on the endothelium of blood vessel activates blood FXII as beginning of coagulation named surface activation. Extrinsic pathway of blood coagulation: Stimulus activates tissue factor (FIII) as beginning of coagulation. Extrinsic pathway of blood coagulation is faster than intrinsic pathway of blood coagulation because its steps are more simple. *Basic steps of blood coagulation [typical positive feedback]: Prothrombin activator forming [FXa-Va-Ca2+-phospholipid] Step 1
Prothrombin
thrombin
Step 2
Fibrinogen fibrin (clot) Step 3 Hemophilia A, B, C in the clinic results from deficiency of FVIII, FIX, FXI in the blood, respectively.
Tissue FactorTF
TF+ Ca2+ -TF a a-TF Ca2+ PL
PL: phospholipid
Intrinsic pathway
Eyewinker surface
Ca2+ HK a a S K PK
Ca2+ PL
a Ca2+ a PL a Ca2+ a PL
a
a Ca2+
CLa
Cellular anticoagulative system: Liver cell and reticular endothelial cell could engulf blood clotting factor, tissue factor, prothrombin complex and soluble fibrin monomer. Humoral anticoagulative system: 1. Amino acid protease inhibitors in blood include antithrombin III, Clinhibitor, 1 antitrypsin, 2 antiplasmin, 2 huge globin, heparin coenzyme II, protease nexin-1 (PN-1) to combine with FIXa, FXa, FXIa, FXIIa and thrombin and then inactivate them for anticoagulation. Heparin can intensify functions of antithrombin III. 2. Protein C system are protein C (PC), thrombomodulin (TM), protein S and Protein C inhibitors. Main functions of PC consist in It inactivates FVa, FVIIIa with phospholipid and Ca2+; It blocks FXa combining with platelet phospholipid membrane to reduce prothrombin activation; It stimulates plasminogen activators release to trigger fibrinolysis; Protein S is a coenzyme of PC and greatly intensify functions of PC. 3. Tissue factor pathway inhibitor (TFPI) mainly coming from vessel endothelial cells inhibits FXa and inactivates FVIIa-TF complex to block extrinsic pathway of coagulation with negative feed back. 4. Heparin used in the clinic widely is due to It combines with antithrombin III to increase functions of antithrombin III; It stimulates vessel endothelial cell greatlu releasing TFPI and other anticoagulative material; It intensifies PC activation and stimulates vessel endothelial cell releasing plasminogen activators to increase fibrinolysis. [lower molecular weight heparin is less hemorrhage]
4.Fibrinolysis
Fibrinolytic system is involved in fibrinolysis, tissue repair and vessel rebirth. Two fibrinolytic systems: cellular one and plasma one. The former is leucocyte, macrophage, endothelial cell, mesothelial cell and platelet to engulf and digest fibrin. The latter is plasminogen activators (PA) and its inhibitors (PAI), plasminogen, plasmin. Basic steps:
Endothelial cells (Extrinsic
pathway ) (Urokinase, uPA)
tPA Plasminogen
uPA
PAI-1
Plasmin
Fibrin dissolution
Fibrin or fibrinogen
Main fibrinolytic inhibitors: They are plasminogen activator inhibitor type-1 (PAI-1, in platelet), 2antiplasmin (in liver), 2-huge globin, 1-antitrypsin, antithrombin III, alexin C1 inhibitor. PAI-1 synthesis and release: PAI-1 made by endothelial cell, smooth muscular cell, mesothelial cell, megakaryocyte is stored in platelet with inactive form. Some factors such as thrombin, IL-1, TNF, etc stimulate its release from platelet. PAI-1 function: It inhibits tPA (tissue-type plasminogen activator) limiting local fibrinolysis of thrombus. 2-antiplasmin characteristics: (1) Quick effect, (2) Inhibit plasminogen adhering to fibrin; (3) Combine with fibrin chain and block fibrinolysis Clinic relation: Innate deficiency of 2-antiplasmin often brings about serious hemorrhage.
V. Blood Group
History: ABO blood group system was firstly found by Landsteiner in 1901.
Definition for blood group*: Types of specific antigens on the blood cell.
Agglutination: Combination of the same antigen (or named agglutinogen, glycoprotein/glycolipid on the membrane of blood cell) and antibody (or named agglutinin, r-globin in serum) results in harmful immune reactions showing hemolysis.
Human leukocyte antigen, HLA have widespread distribution in the body and involves in immune repulsive reaction of organ transplant. Platelet antigens such as PI, Zw, Ko, etc may bring about fever heat when transfusion occur.
1. RBC Agglutination
Antigen-Antibody Harmful immune Reaction
Blood Coagulation
RBC Agglutination
Antigen: Its genes are located at allele on euchromosome, namely, expressed gene.
Genotpye is genetic gene in blood group system and phenotype is antigen produced by corresponding genetic gene and amorph is noneffective allele. Genes in the blood system decide differential specific antigen on the membrane with control of enzymatic activity.
Crude antibody: It is the unexposed antibody to correlative RBC, e.g., IgM in ABO blood group system which can not pass through placenta for the sake of big molecule.
Immune antibody: Various extraordinary RBC antigens (transfusion or parturition) sensitize lymphatic cells producing antibody such as Rh, Kell, Duffy, kidd, which belong to IgG (small molecule) and IgM (big molecule).
Number: 23 types, 193 antigens, more important blood groups are ABO, Rh, MNSs, Lutheran, kell, Lewis, duff, kidd, etc and all of them could result in hemolysis during transfusion. ABO blood group system:
Antigen on the RBC A B Antibody in the serum Anti-B Anti-A Anti-A+Anti-B
Blood group A B
AB
O
A+B
O(H)-antigen
A-antigen
B-Antigen
Galactose
Sugar
N-acetamide galactose
Inheritance: The A, B, H agglutinogen in ABO blood group system controlled by gene which is located at allele on No.9 chromosome (9q34.1-q34.2). Genotype and Phenotype:
O O AA
O O, A
A, B, AB B, AB
AO
BB BO BA ABO ABA ABB
O, A
O, B O, B O, A, B, AB A,B A , B, AB A , B, AB
B, AB
A, AB A, AB ____ O, AB O O
ABAB
A , B, AB
Mid Europe: Type A 40%, Type O 40%, Type B 10%, Type AB 6%. America aborigines: Type O 90%. China Han nationality: Type A 31.31%, Type B 28.06%, Type AB 9.77%, Type O 30.86%. Other chinese minority is different. Bloog group can be used in research on anthropology
Rh antigen (Rh factor) is about 40 kinds and Rh factors related to clinic are D, E, C, c, e and most important is D antigen. Membrane of RBC has D antigen meaning Rh Positive, otherwise, Rh negative. Most of people (99) are Rh Positive and less than 1% persons are Rh negative. Rh blood group characteristics: Immune antobody and incomplete antibody, IgG; while ABO blood group, crude antibody and complete antibody,IgM. Rh blood group system and clinic work Transfusion and pregnacy [Clinic meaning]
5. Principle of Transfusion
Transfusion is widely used in clinic treatment. Principle of transfusion*: 1. Identification of blood group must be taken before transfusion. 2. Cross-match test must be done before transfusion. 3. The same tpyes of blood group for transfusion should be firstly considered. 4. The different tpyes of blood group for transfusion should be very careful, small amount and slow import and if condition is better, changes in the same tpyes of blood group for transfusion.
Receiver
Serum
Main side of agglutination
Serum
Decision
+ -
+, +
+: Agglutination; -: No agglutination
Types of Transfusion
According to source of transfusion, allogenetic transfusion (more use), autologous transfusion. According to component of transfusion, whole blood transfusion, transfusion of blood components Autologous transfusion has some advantages:
It decreases infection. It blocks syndrome (fever, hemolysis) induced by allogenetic transfusion. It stimulates bone marrow hemopoiesis towards RBC.
Summarization
PLEASE TAKE DOWN
1. Please describe classification and main effects of leucocyte. 2. What is the elementary process of blood
Guide of Reference
. . . : , 2000. , , . . : , 2000. , , . . : , 2001. . . , : , 2005. , , . . : , 2000. , . . : , 1999. Ding L, Lu S, Batchu R, et al. Bone marrow stromal cells as a vehicle for gene transfer. Gene Ther, 1999, 6(9): 1611-1616. 8. Humeau L, Bardin F, Maroc C, et al. Phenotypic, molecular, and functional characterization of human peripheral blood, CD34+/Thy1+ cells. Blood, 1996, 87(3): 949-955. 9. Kaushansky K. Thrombopoietin: accumulating evidence for an important biological effect on the hematopoietic stem cell. Ann N Y Acad Sci, 2003, 996: 39-43. 10. Berne RM, Levy MN, Koeppen BMI, Stanton BA. Physiology, 5th ed, St Louis: Mosby Electronic Production, 2004. 11. Guyton AC, Hall JE. TEXTBOOK OF MEDICAL PHYSIOLOGY, 10th ed, Philadelphia: W.B. Saunders Co, 2000. 12. Berardi AC, Wang A, Levine JD, et al. Functional isolation and characterization of human hematopoietic stem cells. Science, 1995, 267(5194): 104-108. 13. Fox SI. Human physiology, 7th ed, New York: McGraw-Hill Co Inc, 2002. 14.Davies A, Blakeley AGH, Kidd C. Human physiology. Edinburgh: Churchill Livingston, 2001. 1. 2. 3. 4. 5. 6. 7.